MX2015008486A - Composiciones y metodos para tratar infecciones bacterianas. - Google Patents
Composiciones y metodos para tratar infecciones bacterianas.Info
- Publication number
- MX2015008486A MX2015008486A MX2015008486A MX2015008486A MX2015008486A MX 2015008486 A MX2015008486 A MX 2015008486A MX 2015008486 A MX2015008486 A MX 2015008486A MX 2015008486 A MX2015008486 A MX 2015008486A MX 2015008486 A MX2015008486 A MX 2015008486A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- bacterial infections
- compositions
- treating bacterial
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Se dan a conocer composiciones y métodos para el tratamiento de infecciones bacterianas farmacéuticas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN117MU2013 | 2013-01-14 | ||
PCT/IB2014/058221 WO2014108872A1 (en) | 2013-01-14 | 2014-01-13 | Compositions and methods for treating bacterial infections |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015008486A true MX2015008486A (es) | 2015-09-10 |
MX363631B MX363631B (es) | 2019-03-29 |
Family
ID=50336354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015008486A MX363631B (es) | 2013-01-14 | 2014-01-13 | Composiciones y metodos para tratar infecciones bacterianas. |
Country Status (12)
Country | Link |
---|---|
US (4) | US9433613B2 (es) |
JP (1) | JP6480870B2 (es) |
KR (1) | KR20150089086A (es) |
CN (1) | CN104884092A (es) |
AU (2) | AU2014206087A1 (es) |
BR (1) | BR112015016033A8 (es) |
CA (1) | CA2890894C (es) |
MX (1) | MX363631B (es) |
RU (1) | RU2676482C2 (es) |
SG (1) | SG11201503661QA (es) |
WO (1) | WO2014108872A1 (es) |
ZA (1) | ZA201503474B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102340010B1 (ko) * | 2013-10-22 | 2021-12-16 | 욱크하르트 리미티드 | 항균제를 포함하는 제약학적 조성물 |
NZ728036A (en) * | 2014-01-21 | 2019-12-20 | Wockhardt Ltd | Pharmaceutical compositions comprising antibacterial agents |
KR102173632B1 (ko) | 2014-04-18 | 2020-11-03 | 욱크하르트 리미티드 | 항균 물질들을 포함하는 약학 조성물 |
US11084833B2 (en) | 2016-10-10 | 2021-08-10 | The Johns Hopkins University | Antibacterial agents against D,D- and L,D-transpeptidases |
CN107823213A (zh) * | 2017-09-16 | 2018-03-23 | 安徽华澳生物技术有限公司 | 一种肉猪抗生素药物 |
US11905286B2 (en) | 2018-08-09 | 2024-02-20 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5994340A (en) * | 1997-08-29 | 1999-11-30 | Synphar Laboratories, Inc. | Azetidinone derivatives as β-lactamase inhibitors |
EP1755661B1 (en) * | 2004-05-12 | 2014-03-12 | The Brigham And Women's Hospital, Inc. | Gelsolin for use in treating infections |
US8084445B2 (en) * | 2004-08-13 | 2011-12-27 | Schering-Plough Animal Health Corporation | Pharmaceutical formulation |
WO2007129176A2 (en) * | 2006-04-28 | 2007-11-15 | Wockhardt Ltd | Improvements in therapy for treating resistant bacterial infections |
RU2578370C2 (ru) * | 2011-08-27 | 2016-03-27 | Вокхардт Лимитед | Производные 1,6- диазабицикло [3,2,1] октан-7-она и их применение при лечении бактериальных инфекционных болезней |
US8796257B2 (en) * | 2011-12-02 | 2014-08-05 | Naeja Pharmaceutical Inc. | Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors |
-
2014
- 2014-01-13 CN CN201480003721.6A patent/CN104884092A/zh active Pending
- 2014-01-13 RU RU2015134149A patent/RU2676482C2/ru not_active Application Discontinuation
- 2014-01-13 SG SG11201503661QA patent/SG11201503661QA/en unknown
- 2014-01-13 KR KR1020157017477A patent/KR20150089086A/ko active Search and Examination
- 2014-01-13 WO PCT/IB2014/058221 patent/WO2014108872A1/en active Application Filing
- 2014-01-13 BR BR112015016033A patent/BR112015016033A8/pt not_active Application Discontinuation
- 2014-01-13 US US14/442,135 patent/US9433613B2/en active Active - Reinstated
- 2014-01-13 MX MX2015008486A patent/MX363631B/es unknown
- 2014-01-13 AU AU2014206087A patent/AU2014206087A1/en not_active Abandoned
- 2014-01-13 JP JP2015552184A patent/JP6480870B2/ja not_active Expired - Fee Related
- 2014-01-13 CA CA2890894A patent/CA2890894C/en not_active Expired - Fee Related
-
2015
- 2015-05-18 ZA ZA2015/03474A patent/ZA201503474B/en unknown
-
2016
- 2016-03-21 US US15/076,004 patent/US9636331B2/en not_active Expired - Fee Related
-
2017
- 2017-03-01 US US15/446,684 patent/US20170172994A1/en not_active Abandoned
- 2017-06-09 AU AU2017203932A patent/AU2017203932B2/en not_active Ceased
-
2018
- 2018-05-17 US US15/982,974 patent/US20180263969A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20180263969A1 (en) | 2018-09-20 |
MX363631B (es) | 2019-03-29 |
AU2017203932A1 (en) | 2017-07-06 |
BR112015016033A2 (pt) | 2017-07-11 |
KR20150089086A (ko) | 2015-08-04 |
BR112015016033A8 (pt) | 2018-01-23 |
AU2014206087A1 (en) | 2015-05-28 |
RU2676482C2 (ru) | 2018-12-29 |
US20170172994A1 (en) | 2017-06-22 |
JP2016504411A (ja) | 2016-02-12 |
US9433613B2 (en) | 2016-09-06 |
JP6480870B2 (ja) | 2019-03-13 |
CA2890894C (en) | 2019-06-11 |
US20160045480A1 (en) | 2016-02-18 |
CA2890894A1 (en) | 2014-07-17 |
ZA201503474B (en) | 2016-11-30 |
RU2015134149A (ru) | 2017-02-16 |
US9636331B2 (en) | 2017-05-02 |
CN104884092A (zh) | 2015-09-02 |
SG11201503661QA (en) | 2015-06-29 |
AU2017203932B2 (en) | 2019-02-14 |
US20160199360A1 (en) | 2016-07-14 |
WO2014108872A1 (en) | 2014-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1225649A1 (zh) | 用於治療細菌性感染的化合物和方法 | |
EP2991638A4 (en) | METHODS OF TREATING BACTERIAL INFECTIONS | |
HK1215378A1 (zh) | 藥物組合物、治療方法及其用途 | |
HK1218293A1 (zh) | 治療細菌感染的化合物和方法 | |
SG11201700621XA (en) | Antibiotic compositions for treating bacterial infections | |
TN2015000411A1 (en) | Ceftolozane antibiotic compositions | |
EP3268010A4 (en) | Compositions and methods for treating bacterial infection | |
EP3468555C0 (en) | COMPOSITIONS FOR USE IN THE TREATMENT OF BACTERIAL INFECTIONS | |
MX363631B (es) | Composiciones y metodos para tratar infecciones bacterianas. | |
HK1213268A1 (zh) | 用於治療細菌感染的甘露糖衍生物 | |
PH12017500602A1 (en) | Methods for treating ocular conditions | |
EP2969003A4 (en) | METHOD AND COMPOSITIONS FOR BACTERIAL INFECTIONS | |
MX2015013021A (es) | 5-bromo-indirrubinas. | |
EP3190893A4 (en) | Compositions and methods for treating and preventing bacterial infections | |
EP3411367A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF INFECTIONS | |
IN2013MU03216A (es) | ||
ZA201608607B (en) | Novel fluoroquinolones and use thereof to treat bacterial infections | |
EP3212183A4 (en) | Synergistic compositions for treating microbial infections | |
EP3116540A4 (en) | Compositions and methods for treating, including preventing, parvovirus infections and related diseases | |
EP3242664A4 (en) | Compositions and methods for treating gastrointestinal infections | |
IN2013DE03375A (es) | ||
AU2013901517A0 (en) | Methods of Treating Bacterial Infections | |
MY180947A (en) | Ceftolozane antibiotic compositions |